Skip to content
EmergingResearch compoundLimited evidence

1,4‑DMAA

Experimental stimulant, a structural relative of the banned 1,3-DMAA; not studied in humans and prohibited in competitive sport.

StimulantSympathomimeticStimulantWakefulnessNorepinephrineDopamine

Pharmacology

ClassStimulant · Wakefulness
Primary targetIndirect sympathomimetic (catecholamine release)
Targets3 receptor targets
Half-lifeNo human pharmacokinetic data
OnsetNo reliable human data (products time it early in the day for energy and focus)
EvidenceLimited evidence
Affected systemsNorepinephrineDopamine

Contents

DETAILED OVERVIEW

What is 1,4-DMAA?

1,4-DMAA is a close structural relative of the banned 1,3-DMAA: a synthetic stimulant that has been found in pre-workout and weight-loss supplements, often to get around the ban on 1,3-DMAA. It is not approved as a medicine or as a supplement ingredient, and in competitive sport it is on the anti-doping list (WADA).

How it works is only inferred from related compounds: it probably increases the release of norepinephrine and dopamine (brain messengers), which would explain alertness and lower appetite, but also higher blood pressure and heart rate. There are no human studies, and the literature is almost entirely about detecting it in supplements, so only early data exist. The closely related 1,3-DMAA has been linked to stroke, heart attack and deaths, so the cardiovascular risk is real here too. Together with MAO-inhibitor medicines or other stimulants there is a risk of a blood pressure crisis; it is contraindicated in pregnancy and breastfeeding.

Mechanism

Indirect sympathomimetic (norepinephrine/dopamine release)

Evidence

Analytical detection only, no human clinical data

Legal status

Unapproved stimulant, prohibited in competitive sport

Receptor profile

  • Norepinephrine and dopamine releaseStrong
  • Sympathetic nervous systemModerate
  • Blood pressure / heart rateStrong

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Elevated blood pressure, sometimes markedly
  • Rapid heart rate, palpitations
  • Jitteriness, anxiety, tremor
  • Headache
  • Sleep disruption, especially with late dosing
  • Unknown human safety: the closely related 1,3-DMAA has been linked to cerebral hemorrhage, heart attack and deaths, and the cardiovascular risk applies here too

Contraindications · 4

  • Cardiovascular disease, hypertension, arrhythmia
  • Pregnancy and breastfeeding: avoid
  • Concurrent MAO inhibitors or other stimulants: risk of hypertensive crisis
  • Competitive athletes: a WADA-prohibited substance that causes an anti-doping violation

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

1,4-DMAA is a close relative of the banned 1,3-DMAA, sold for similar reasons, energy, alertness and appetite suppression, in weight-loss and pre-workout products, often as a way to sidestep the ban on its cousin. There's essentially no human research on it and it's banned in competitive sport, so it's an experimental substance rather than a proven supplement.

Telegram

Have a question about 1,4‑DMAA?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeStimulant
FormulaC7H17N
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.